Tempest Therapeutics, Inc. Increase (Decrease) in Accounts Payable
Tempest Therapeutics, Inc. (TPST) reported Increase (Decrease) in Accounts Payable of -$1.64 million for the 9-month period ending 2018-09-30, per its 10-Q filed 2018-11-09.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInAccountsPayable · last filed 2018-11-09
- Tempest Therapeutics, Inc. increase (decrease) in accounts payable for the quarter ending 2018-09-30 was -$153.00K.
- Tempest Therapeutics, Inc. increase (decrease) in accounts payable for the quarter ending 2018-06-30 was -$115.00K, a 112.54% decline year-over-year.
- Tempest Therapeutics, Inc. increase (decrease) in accounts payable for the quarter ending 2018-03-31 was -$1.37M, a 844.57% decline year-over-year.
- Tempest Therapeutics, Inc. increase (decrease) in accounts payable for the quarter ending 2017-12-31 was -$449.00K.
- Tempest Therapeutics, Inc. increase (decrease) in accounts payable for fiscal 2017 was $68.00K.
- Tempest Therapeutics, Inc. increase (decrease) in accounts payable for fiscal 2016 was -$1.18M.
- Tempest Therapeutics, Inc. increase (decrease) in accounts payable for fiscal 2015 was -$171.00K, a 107.38% decline from fiscal 2014.
- Tempest Therapeutics, Inc. increase (decrease) in accounts payable for fiscal 2014 was $2.32M.
| Period end | Increase (Decrease) in Accounts Payable 3 month | Increase (Decrease) in Accounts Payable 6 month | Increase (Decrease) in Accounts Payable 9 month | Increase (Decrease) in Accounts Payable 12 month | Increase (Decrease) in Accounts Payable 15 month | Increase (Decrease) in Accounts Payable 18 month | Increase (Decrease) in Accounts Payable 21 month | Increase (Decrease) in Accounts Payable 24 month | Increase (Decrease) in Accounts Payable 27 month | Increase (Decrease) in Accounts Payable 30 month | Increase (Decrease) in Accounts Payable 33 month | Increase (Decrease) in Accounts Payable 36 month |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2018-09-30 | -$153.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-09 | -$268.00K derived: sum of 2 quarters · filed 2018-11-09 | -$1.64M 10-Q · filed 2018-11-09 | -$2.09M derived: sum of 4 quarters · filed 2018-11-09 | ||||||||
| 2018-06-30 | -$115.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-09 | -$1.49M 10-Q · filed 2018-08-09 | -$1.93M derived: sum of 3 quarters · filed 2018-08-09 | -$2.52M derived: sum of 4 quarters · filed 2018-11-09 | ||||||||
| 2018-03-31 | -$1.37M 10-Q · filed 2018-05-03 | -$1.82M derived: sum of 2 quarters · filed 2018-05-03 | -$2.40M derived: sum of 3 quarters · filed 2018-11-09 | -$1.49M derived: sum of 4 quarters · filed 2018-11-09 | ||||||||
| 2017-12-31 | -$449.00K derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-15 | -$1.03M derived: sum of 2 quarters · filed 2018-11-09 | -$116.00K derived: sum of 3 quarters · filed 2018-11-09 | $68.00K 10-K · filed 2018-03-15 | ||||||||
| 2017-09-30 | -$584.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-09 | $333.00K derived: sum of 2 quarters · filed 2018-11-09 | $517.00K 10-Q · filed 2018-11-09 | -$22.00K derived: sum of 4 quarters · filed 2018-11-09 | ||||||||
| 2017-06-30 | $917.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-09 | $1.10M 10-Q · filed 2018-08-09 | $562.00K derived: sum of 3 quarters · filed 2018-08-09 | $844.00K derived: sum of 4 quarters · filed 2018-08-09 | ||||||||
| 2017-03-31 | $184.00K 10-Q · filed 2018-05-03 | -$355.00K derived: sum of 2 quarters · filed 2018-05-03 | -$73.00K derived: sum of 3 quarters · filed 2018-05-03 | -$1.37M derived: sum of 4 quarters · filed 2018-05-03 | ||||||||
| 2016-12-31 | -$539.00K derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-15 | -$257.00K derived: sum of 2 quarters · filed 2018-03-15 | -$1.56M derived: sum of 3 quarters · filed 2018-03-15 | -$1.18M 10-K · filed 2018-03-15 | ||||||||
| 2016-09-30 | $282.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-02 | -$1.02M derived: sum of 2 quarters · filed 2017-11-02 | -$639.00K 10-Q · filed 2017-11-02 | -$671.00K derived: sum of 4 quarters · filed 2018-03-15 | ||||||||
| 2016-06-30 | -$1.30M derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-03 | -$921.00K 10-Q · filed 2017-08-03 | -$953.00K derived: sum of 3 quarters · filed 2018-03-15 | -$1.48M derived: sum of 4 quarters · filed 2018-03-15 | ||||||||
| 2016-03-31 | $378.00K 10-Q · filed 2017-05-09 | $346.00K derived: sum of 2 quarters · filed 2018-03-15 | -$181.00K derived: sum of 3 quarters · filed 2018-03-15 | $864.00K derived: sum of 4 quarters · filed 2018-03-15 | ||||||||
| 2015-12-31 | -$32.00K derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-15 | -$559.00K derived: sum of 2 quarters · filed 2018-03-15 | $486.00K derived: sum of 3 quarters · filed 2018-03-15 | -$171.00K 10-K · filed 2018-03-15 | ||||||||
| 2015-09-30 | -$527.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-03 | $518.00K derived: sum of 2 quarters · filed 2016-11-03 | -$139.00K 10-Q · filed 2016-11-03 | $285.00K derived: sum of 4 quarters · filed 2017-03-02 | ||||||||
| 2015-06-30 | $1.04M derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-04 | $388.00K 10-Q · filed 2016-08-04 | $812.00K derived: sum of 3 quarters · filed 2017-03-02 | $1.47M derived: sum of 4 quarters · filed 2017-03-02 | ||||||||
| 2015-03-31 | -$657.00K 10-Q · filed 2016-05-05 | -$233.00K derived: sum of 2 quarters · filed 2017-03-02 | $426.00K derived: sum of 3 quarters · filed 2017-03-02 | $259.00K derived: sum of 4 quarters · filed 2017-03-02 | ||||||||
| 2014-12-31 | $424.00K derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-02 | $1.08M derived: sum of 2 quarters · filed 2017-03-02 | $916.00K derived: sum of 3 quarters · filed 2017-03-02 | $2.32M 10-K · filed 2017-03-02 | ||||||||
| 2014-09-30 | $659.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-05 | $492.00K derived: sum of 2 quarters · filed 2015-11-05 | $1.89M 10-Q · filed 2015-11-05 | $1.26M derived: sum of 4 quarters · filed 2016-02-26 | ||||||||
| 2014-06-30 | -$167.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-10 | $1.23M 10-Q · filed 2015-08-10 | $597.00K derived: sum of 3 quarters · filed 2016-02-26 | $1.17M derived: sum of 4 quarters · filed 2016-02-26 | ||||||||
| 2014-03-31 | $1.40M 10-Q · filed 2015-05-11 | $764.00K derived: sum of 2 quarters · filed 2016-02-26 | $1.34M derived: sum of 3 quarters · filed 2016-02-26 | $607.00K derived: sum of 4 quarters · filed 2016-02-26 | $1.55M 10-Q · filed 2014-05-08 | |||||||
| 2013-12-31 | -$637.00K derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-26 | -$62.00K derived: sum of 2 quarters · filed 2016-02-26 | -$794.00K derived: sum of 3 quarters · filed 2016-02-26 | -$721.00K 10-K · filed 2016-02-26 | $154.00K 10-K · filed 2014-02-27 | |||||||
| 2013-09-30 | $575.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-10 | -$157.00K derived: sum of 2 quarters · filed 2014-11-10 | -$84.00K 10-Q · filed 2014-11-10 | -$278.00K derived: sum of 4 quarters · filed 2015-03-16 | $791.00K 10-Q · filed 2013-11-13 | |||||||
| 2013-06-30 | -$732.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-07 | -$659.00K 10-Q · filed 2014-08-07 | -$853.00K derived: sum of 3 quarters · filed 2015-03-16 | -$388.00K derived: sum of 4 quarters · filed 2015-03-16 | $216.00K 10-Q · filed 2013-08-13 | |||||||
| 2013-03-31 | $73.00K 10-Q · filed 2014-05-08 | -$121.00K derived: sum of 2 quarters · filed 2015-03-16 | $344.00K derived: sum of 3 quarters · filed 2015-03-16 | -$580.00K derived: sum of 4 quarters · filed 2015-03-16 | $948.00K 10-Q · filed 2013-05-15 | |||||||
| 2012-12-31 | -$194.00K derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-16 | $271.00K derived: sum of 2 quarters · filed 2015-03-16 | -$653.00K derived: sum of 3 quarters · filed 2015-03-16 | $599.00K 10-K · filed 2015-03-16 | $875.00K 10-K · filed 2013-02-25 | |||||||
| 2012-09-30 | $465.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-13 | -$459.00K derived: sum of 2 quarters · filed 2013-11-13 | $793.00K 10-Q · filed 2013-11-13 | $1.07M 10-Q · filed 2012-11-13 | ||||||||
| 2012-06-30 | -$924.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-13 | $328.00K 10-Q · filed 2013-08-13 | $605.00K 10-Q · filed 2012-08-14 | |||||||||
| 2012-03-31 | $1.25M 10-Q · filed 2013-05-15 | |||||||||||
| 2011-12-31 | $276.00K 10-K · filed 2014-02-27 | |||||||||||
| 2011-09-30 | $179.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2012-11-13 | $181.00K 10-Q · filed 2012-11-13 | ||||||||||
| 2011-06-30 | $2.00K 10-Q · filed 2012-08-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Aspire Biopharma Holdings, Inc. (ASBP) | United States | $0.012B | -0.60 |
| AEON Biopharma, Inc. (AEON) | United States | $0.013B | -0.36 |
| BIOVIE INC. (BIVI) | United States | $0.012B | |
| MUSTANG BIO, INC. (MBIO) | United States | $0.013B | |
| Vistagen Therapeutics, Inc. (VTGN) | United States | $0.013B | -0.14 |
| ADIAL PHARMACEUTICALS, INC. (ADIL) | United States | $0.012B | |
| Phio Pharmaceuticals Corp. (PHIO) | United States | $0.012B | -0.92 |
| Scienture Holdings, Inc. (SCNX) | United States | $0.012B | -0.38 |
| LISATA THERAPEUTICS, INC. (LSTA) | United States | $0.014B | -2.13 |
| KIORA PHARMACEUTICALS INC (KPRX) | United States | $0.012B |